Where Technology meets Opportunity in Science and Engineering
Home»Latest 30days News on Medical, Biotech/Pharma - weSRCH
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech:-Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine:-Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech:-Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business:-Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News


    Total record(s) 1136 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
     
    NIH: without budget cuts, we'd have Ebola vaccine - In-PharmaTechnologist.com
      BASF Pharma solutions for Orally Disintegrating Tablets BASF SE. BA Enhancement Series: Technology Selection Bend Research. Novel solutions for pediatrics and patients with swallowing difficulties. Capsugel. Increase tabl ....more | Save |  Share  Email 22nd Oct 2014 
     
    Oral influenza vaccine one step closer, says Vaxart - In-PharmaTechnologist.com
      Last year, Prokarium received a grant of 400,000 ($600,000) from the UK's innovation agency, the Technology Strategy Board (TSB), to help develop its oral delivery platform and two candidates targeting typhoid and Clo ....more | Save |  Share  Email 22nd Oct 2014 
     
    Juncked: Plan to move EMA from DG Health to DG Enterprise is abandoned - In-PharmaTechnologist.com
      BASF Pharma solutions for Orally Disintegrating Tablets BASF SE. BA Enhancement Series: Technology Selection Bend Research. Novel solutions for pediatrics and patients with swallowing difficulties. Capsug ....more | Save |  Share  Email 22nd Oct 2014 
     
    FDA approves Auxilium's Xiaflex to treat Dupuytren's Contracture - Pharmaceutical Business Review
      Auxilium Pharmaceuticals chief executive officer and president Adrian Adams said the company is happy with the FDA approval of the sBLA for a labeling expansion for Xiaflex for the treat ....more | Save |  Share  Email 22nd Oct 2014 
     
    NewLink, Genentech ink licensing deal for development of NLG919 - Pharmaceutical Business Review
      The company will also provide research funding to NewLink for support of the research collaboration, while NewLink will continue to pursue development activities related to NLG919 in combination with its ne ....more | Save |  Share  Email 22nd Oct 2014 
     
    Juncker confirms DG Health and Consumers will keep responsibility for EMA - In-PharmaTechnologist.com
      DG SANCO will retain responsibility for the EMA according to European Commission President-elect Jean-Claude Juncker, who confirmed he has abandoned plans to hand the agency to DG Enterprise during an ....more | Save |  Share  Email 22nd Oct 2014 
     
    Million Pound Lift: Bodybuilder with diabetes sets $1M fundraising goal - KVAL
      KVAL EUGENE, Ore. - At 17, Jacob Miner didn't feel well. He was eating a lot. And he was constantly tired - and losing weight. "When we he was diagnosed with diabetes, he had lost about 20-25 pounds in weight while l ....more | Save |  Share  Email 22nd Oct 2014 
     
    Diabetes forum Nov. 5 - The Hillsdale Daily News
      Topics to be covered include, achieving good glucose control, learning about effective self-management, developing a balanced, healthy lifestyle, planning and prioritizing diabetes management, overcoming fears surrounding diabetes and finding resources&n ....more | Save |  Share  Email 21st Oct 2014 
     
    Pharmaceuticals: Global Industry Almanac, MarketLine - PR Newswire (press release)
      Global Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading c ....more | Save |  Share  Email 21st Oct 2014 
     
    UPDATE 3-Third Point's Loeb urges breakup of biotech company Amgen - Reuters
      New York Times (Adds link to Breakingviews). By Svea Herbst-Bayliss. BOSTON Oct 21 (Reuters) - Hedge fund manager Daniel Loeb told investors on Tuesday he urged U.S. biotechnology company Amgen Inc to split into two separat ....more | Save |  Share  Email 21st Oct 2014 
     
    Pharmaceuticals: Global Industry Guide - PR Newswire (press release)
      Global Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading companies inclu ....more | Save |  Share  Email 21st Oct 2014 
     
    Yeast infection biotech remains private: Viamet Pharmaceuticals withdraws $75 ... - Renaissance Capital
      ETF Trends Performance Disclosure: Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investmen ....more | Save |  Share  Email 21st Oct 2014 
     
    GENETWORx Launches a New Personal Health Panel for Advanced Diagnosis ... - Virtual-Strategy Magazine (press release)
      The new panel also meshes well with our current pharmacogenetics panel, and together these results can be integrated into the overall treatment consideration to allow for mor ....more | Save |  Share  Email 21st Oct 2014 
     
    GENETWORx Launches a New Personal Health Panel for Advanced Diagnosis ... - GlobeNewswire (press release)
      The new panel also meshes well with our current pharmacogenetics panel, and together these results can be integrated into the overall treatment consideration to allow for more efficient ....more | Save |  Share  Email 21st Oct 2014 
     
    Alopecia Areata: Humira May Improve, or Worsen, Hair Loss - Medical Research News and Interviews on MedicalResearch.com (blog)
      Medical Research: What are the main findings of the study? What was most surprising about the results? Dr. Leger: Alopecia areata is a T-cell mediated autoimmune disease. As su ....more | Save |  Share  Email 21st Oct 2014 
     
    Cambridge biotech launches in hot field of immunotherapy with $12M - Boston Business Journal (blog)
      A new biotech aimed at a new field of drug development based on using the immune system to fight cancer launched today with $12 million in funding. Unum Therapeutics is being backed by Fidelity Bioscienc ....more | Save |  Share  Email 21st Oct 2014 
     
    Expert offers insight into pharmacotherapy in IBD, individualized treatment - Healio
      Bernstein, of the University of Manitoba and director of the IBD Clinical and Research center in Winnipeg, Canada, suggested that thiopurines may have a role in Crohn's disease, and that combination therapy with im ....more | Save |  Share  Email 21st Oct 2014 
     
    Out of the Ashes: Ashten Smith-Gooden hasn't let diabetes define her - Daily Californian
      Daily Californian After two and a half hours of waiting at the hospital, Ashten Smith-Gooden's parents stepped away from their 7-year-old child to confront the doctor. They readied themselves for the worst t ....more | Save |  Share  Email 21st Oct 2014 
     
    Akron Biotech Expanding to New, State-of-the-Art Biotechnology Facility - Business Wire (press release)
      BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotechnology, LLC (Akron Biotech), which provides novel technologies for cell therapy and regenerative medicine discovery, development, and commercialization ....more | Save |  Share  Email 21st Oct 2014 
     
    Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner ... - FierceBiotech
      Washington Business Journal PLYMOUTH MEETING, Pa., Oct. 21, 2014 -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million ....more | Save |  Share  Email 21st Oct 2014 
     
    Total record(s) 1136 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>

     
    Subscribe
    x